Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results
- PMID: 11677005
- DOI: 10.1016/s0022-510x(01)00611-6
Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results
Abstract
Creatine supplementation in humans has been reported to enhance power and strength both in normal subjects and in patients with various neuromuscular diseases. The purpose of this study was to examine the effects of supplementation on exercise performance and maximal voluntary isometric muscular contraction (MVIC) in Amyotrophic Lateral Sclerosis (ALS) patients. We report the results obtained in 28 patients with probable/definite ALS. In each patient we acquired the dynamometric measurement of MVIC in 10 muscle groups of upper and lower limbs and a measure of fatigue by means of an high-intensity intermittent protocol in elbow flexors and knee extensors muscles. All patients completed the protocols at the baseline and after supplementation of 20 g per day for 7 days and after supplementation of 3 g per day for 3 and 6 months. MVIC increased after 7 days of supplementation in 20 patients (70%) in knee extensors and in 15 (53%) of them also in elbow flexors. A statistically significant difference between pre and post-treatment mean values of MVIC was found both in elbow flexors (P<0.05) and knee extensors (p<0.04). The analysis of the slopes of fatigue test showed a statistically significant improvement after 7 days of supplementation in 11 patients (39%) in elbow flexors and in 9 patients (32%) also in knee extensors muscles. During the 6-month follow-up period all the examined parameters showed a linear progressive decline. In conclusion, our preliminary results have demonstrated that supplementation temporary increases maximal isometric power in ALS patients so it may be of potential benefit in situations such as high intensity activity and it can be proposed as a symptomatic treatment.
Similar articles
-
Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis.J Neurol Sci. 2001 Oct 15;191(1-2):55-9. doi: 10.1016/s0022-510x(01)00624-4. J Neurol Sci. 2001. PMID: 11676992 Clinical Trial.
-
Creatine supplementation attenuates the rate of fatigue development during intermittent isometric exercise performed above end-test torque.Exp Physiol. 2020 Dec;105(12):2073-2085. doi: 10.1113/EP088910. Epub 2020 Oct 18. Exp Physiol. 2020. PMID: 33073449
-
Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults.J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):11-9. doi: 10.1093/gerona/58.1.b11. J Gerontol A Biol Sci Med Sci. 2003. PMID: 12560406 Clinical Trial.
-
Creatine for amyotrophic lateral sclerosis/motor neuron disease.Cochrane Database Syst Rev. 2010 Jun 16;(6):CD005225. doi: 10.1002/14651858.CD005225.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2012 Dec 12;12:CD005225. doi: 10.1002/14651858.CD005225.pub3. PMID: 20556761 Updated. Review.
-
The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders.CNS Drugs. 2004;18(14):967-80. doi: 10.2165/00023210-200418140-00002. CNS Drugs. 2004. PMID: 15584767 Review.
Cited by
-
Amyotrophic Lateral Sclerosis: A Diet Review.Foods. 2021 Dec 17;10(12):3128. doi: 10.3390/foods10123128. Foods. 2021. PMID: 34945679 Free PMC article. Review.
-
A comprehensive review of amyotrophic lateral sclerosis.Surg Neurol Int. 2015 Nov 16;6:171. doi: 10.4103/2152-7806.169561. eCollection 2015. Surg Neurol Int. 2015. PMID: 26629397 Free PMC article. Review.
-
Creatine in Health and Disease.Nutrients. 2021 Jan 29;13(2):447. doi: 10.3390/nu13020447. Nutrients. 2021. PMID: 33572884 Free PMC article.
-
Role of creatine supplementation on exercise-induced cardiovascular function and oxidative stress.Oxid Med Cell Longev. 2009 Sep-Oct;2(4):247-54. doi: 10.4161/oxim.2.4.9415. Oxid Med Cell Longev. 2009. PMID: 20716911 Free PMC article. Clinical Trial.
-
Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease.Brain Commun. 2020 Sep 18;2(2):fcaa152. doi: 10.1093/braincomms/fcaa152. eCollection 2020. Brain Commun. 2020. PMID: 33543134 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous